免疫療法治療薬の世界市場予測（～2021）：薬種類別（成人用ワクチン、チェックポイント阻害剤、インターフェロンアルファ）、治療分野別、需要先別、地域別...市場調査レポートについてご紹介

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency ‘
1.4 Limitations
1.5 Stakeholders

2 Research Methodology (Page No. – 18)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary (Page No. – 25)
3.1 Introduction
3.2 Conclusion

4 Premium Insights (Page No. – 30)
4.1 Global Immunotherapy Drugs Market Overview
4.2 Market: By Therapy Area & Region
4.3 Market: Geographic Snapshot
4.4 Market, By Type of Drug
4.5 Life Cycle Analysis, By Region (2016)

5 Market Overview (Page No. – 33)
5.1 Introduction
5.1.1 Drivers
5.1.1.1 Increasing Adoption of Targeted Therapy Over Traditional Therapy
5.1.1.2 Emergence of Biosimilars
5.1.1.3 Increasing Demand for Mabs
5.1.1.4 High Prevalence Rate of Lifestyle Diseases
5.1.1.5 Fast Track and Orphan Drug Designations
5.1.2 Restraints
5.1.2.1 High Cost of Immunotherapy Treatment
5.1.2.2 High Attrition Rate in the Product Development Cycle
5.1.3 Opportunities
5.1.3.1 Emerging Markets
5.1.3.2 Immunotherapy to Replace Chemotherapy in Cancer Treatment
5.1.4 Challenge
5.1.4.1 Impending Patent Expiry of Top-Selling Biologics

6 Industry Insights (Page No. – 39)
6.1 Introduction
6.2 Epidemiology Coverage
6.2.1 Cancer Epidemiology
6.2.2 Autoimmune Disease Epidemiology
6.3 Pricing and Reimbursement Scenario
6.3.1 U.S.
6.3.2 U.K.
6.3.3 France
6.3.4 Germany
6.3.5 Other European Countries
6.3.6 Japan
6.4 Research Funding & Government Initiatives
6.5 Pipeline Drugs
6.5.1 Phase 1
6.5.2 Phase I/II
6.5.3 Phase II
6.5.4 Phase II/III
6.5.5 Phase III
6.5.6 Application Submitted
6.5.7 Promising Molecules
6.6 Industry Trends
6.7 Key Products Expected to Be Launched
6.8 Treatment Protocols and Line of Therapies
6.8.1 First-Line Therapy
6.8.2 Second-Line Therapy
6.8.3 Other Treatments
6.9 Burning Issues

7 Immunotherapy Drugs Market, By Type of Drug (Page No. – 67)
7.1 Introduction
7.2 Monoclonal Antibodies
7.3 Adult Vaccines
7.3.1 Preventive Vaccines
7.3.2 Therapeutic Vaccines
7.4 Checkpoint Inhibitors
7.5 Interferons Alpha & Beta
7.6 Interleukins
7.7 Other Drugs

8 Immunotherapy Drugs Market, By Therapy Area (Page No. – 79)
8.1 Introduction
8.2 Cancer
8.3 Autoimmune and Inflammatory Diseases
8.4 Infectious Diseases
8.5 Other Therapy Areas

9 Immunotherapy Drugs Market, By End User (Page No. – 88)
9.1 Introduction
9.2 Hospitals
9.3 Clinics
9.4 Other End Users

10 Immunotherapy Drugs Market, By Region (Page No. – 93)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. – 116)
11.1 Introduction
11.2 Strategic Analysis
11.3 Market Share Analysis
11.4 Competitive Situation and Trends
11.4.1 Regulatory Approvals
11.4.2 Collaborations
11.4.3 Agreements
11.4.4 Acquisitions
11.4.5 Expansions

12 Company Profiles (Page No. – 124)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 Introduction
12.2 F. Hoffmann-La Roche AG
12.3 Merck & Co., Inc.
12.4 Novartis International AG
12.5 Johnson & Johnson (A Parent Company of Janssen Biotech, Inc.)
12.6 Glaxosmithkline PLC
12.7 Amgen Inc.
12.8 Abbvie
12.9 Astrazeneca
12.10 Bristol-Myers Squibb
12.11 ELI Lilly and Company

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 157)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Other Developments
13.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.5 Introducing RT: Real-Time Market Intelligence
13.6 Available Customizations
13.7 Related Reports
13.8 Author Details